Key result
Two KCNQ2 variants at the intron 6-exon 7 boundary differentially affected mRNA splicing and produced Kv7.2 subunits with distinct sensitivities to PIP2 and CaM regulation, impeding channel function.
Why the study?
Pathogenic KCNQ2 variants cause diverging epileptic phenotypes, and understanding their molecular mechanisms and clinical correlations is relevant for clinical management.
Two KCNQ2 variants causing distinct epileptic phenotypes differentially affect mRNA splicing and channel sensitivity to PIP2 and CaM regulation.
KCNQ2 splicing variants may refine epilepsy subtyping; leaves open validation in larger cohorts before guiding therapy.
Pathogenic variants in KCNQ2 encoding for Kv7.2 potassium channel subunits have been found in patients affected by widely diverging epileptic phenotypes, ranging from Self-Limiting Familial Neonatal Epilepsy (SLFNE) to severe Developmental and Epileptic Encephalopathy (DEE). Thus, understanding the pathogenic molecular mechanisms of KCNQ2 variants and their correlation with clinical phenotypes has a relevant impact on the clinical management of these patients. In the present study, the genetic, biochemical, and functional effects prompted by two variants, each found in a non-familial SLNE or a DEE patient but both affecting nucleotides at the KCNQ2 intron 6-exon 7 boundary, have been investigated to test whether and how they affected the splicing process and to clarify whether such mechanism might play a pathogenetic role in these patients. Analysis of KCNQ2 mRNA splicing in patient-derived lymphoblasts revealed that the SLNE-causing intronic variant (c.928-1G > C) impeded the use of the natural splice site, but lead to a 10-aa Kv7.2 in frame deletion (Kv7.2 p.G310Δ10); by contrast, the DEE-causing exonic variant (c.928G > A) only had subtle effects on the splicing process at this site, thus leading to the synthesis of a full-length subunit carrying the G310S missense variant (Kv7.2 p.G310S). Patch-clamp recordings in transiently-transfected CHO cells and primary neurons revealed that both variants fully impeded Kv7.2 channel function, and exerted strong dominant-negative effects when co-expressed with Kv7.2 and/or Kv7.3 subunits. Notably, Kv7.2 p.G310S, but not Kv7.2 p.G310Δ10, currents were recovered upon overexpression of the PIP 2 -synthesizing enzyme PIP5K, and/or CaM; moreover, currents from heteromeric Kv7.2/Kv7.3 channels incorporating either Kv7.2 mutant subunits were differentially regulated by changes in PIP 2 availability, with Kv7.2/Kv7.2 G310S/Kv7.3 currents showing a greater sensitivity to PIP 2 depletion when compared to those from Kv7.2/Kv7.2 G310Δ10/Kv7.3 channels. Altogether, these results suggest that the two variants investigated differentially affected the splicing process at the intron 6-exon 7 boundary, and led to the synthesis of Kv7.2 subunits showing a differential sensitivity to PIP 2 and CaM regulation; more studies are needed to clarify how such different functional properties contribute to the widely-divergent clinical phenotypes.
No takes yet. Share an insight, caveat, or question.
Mosca et al. (2022) studied Self-Limiting Familial Neonatal Epilepsy (SLFNE) and severe Developmental and Epileptic Encephalopathy (DEE). KCNQ2 variants (c.928-1G > C and c.928G > A) was evaluated on KCNQ2 mRNA splicing and Kv7.2 channel function. Two KCNQ2 variants at the intron 6-exon 7 boundary differentially affected mRNA splicing and produced Kv7.2 subunits with distinct sensitivities to PIP2 and CaM regulation, impeding channel function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: